The global anatomic pathology market is expected to reach a value of $30.9 billion by 2027, growing at a CAGR of 6.1% during the forecast period. The market is driven by the increasing prevalence of chronic diseases, growing demand for personalized medicine, advancements in diagnostic technologies, and rising healthcare expenditure.
By Product & Services:
The anatomic pathology market can be segmented into instruments, consumables, and services. The consumables segment holds the largest market share, owing to the high usage of reagents, antibodies, and probes in diagnostic procedures. The instruments segment is expected to witness significant growth due to the increasing adoption of automated pathology instruments for faster and accurate diagnosis.
Application:
The anatomic pathology market is segmented based on applications such as disease diagnosis, drug discovery, and development. Disease diagnosis holds the largest market share, driven by the rising incidence of cancer, infectious diseases, and autoimmune disorders. The drug discovery and development segment is expected to witness rapid growth due to the increasing demand for personalized medicine and targeted therapies.
End-use:
The anatomic pathology market is categorized by end-use into hospitals, diagnostic laboratories, academic and research institutes, and others. Hospitals hold the largest market share, attributed to the high patient footfall and the availability of advanced diagnostic facilities. Diagnostic laboratories are expected to witness significant growth due to the increasing outsourcing of pathology testing services and the rising demand for accurate diagnostic solutions.